of Health and Human Services, acting through the Commissioner of Food and Drugs, shall require any abortion drug, including any abortion drug approved by the Food and Drug Administration before the date of enactment of this Act, to have a risk evaluation and mitigation strategy requiring that— (1) within 15 days of becoming aware of any death or other adverse event in a patient associated with the use of such abortion drug, a health care provider shall— (A) report such death or adverse event to the Food and Drug Administration and to the manufacturer of such abortion drug